IDEXX Laboratories, Inc. (IDXX)
USD 392.3
(2.74%)
USD 392.3
(2.74%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 493.94 Million USD | -60.03% |
| 2022 | 1.23 Billion USD | 58.59% |
| 2021 | 779.24 Million USD | 48.55% |
| 2020 | 524.55 Million USD | -41.54% |
| 2019 | 897.34 Million USD | 2.38% |
| 2018 | 876.49 Million USD | -18.34% |
| 2017 | 1.07 Billion USD | 2.31% |
| 2016 | 1.04 Billion USD | 0.78% |
| 2015 | 1.04 Billion USD | 80.6% |
| 2014 | 576.46 Million USD | 286.02% |
| 2013 | 149.33 Million USD | 1674.44% |
| 2012 | -9.48 Million USD | -115.17% |
| 2011 | 62.52 Million USD | 364.54% |
| 2010 | -23.63 Million USD | -237.77% |
| 2009 | 17.15 Million USD | -77.89% |
| 2008 | 77.61 Million USD | 323.57% |
| 2007 | 18.32 Million USD | 133.59% |
| 2006 | -54.54 Million USD | 18.11% |
| 2005 | -66.6 Million USD | -46.46% |
| 2004 | -45.47 Million USD | 75.48% |
| 2003 | -185.43 Million USD | -64.37% |
| 2002 | -112.81 Million USD | -93.55% |
| 2001 | -58.28 Million USD | -55.28% |
| 2000 | -37.53 Million USD | 31.75% |
| 1999 | -55 Million USD | 44.83% |
| 1998 | -99.7 Million USD | 3.11% |
| 1997 | -102.9 Million USD | 17.48% |
| 1996 | -124.7 Million USD | 15.51% |
| 1995 | -147.6 Million USD | -485.71% |
| 1994 | -25.2 Million USD | -33.33% |
| 1993 | -18.9 Million USD | -9.88% |
| 1992 | -17.2 Million USD | -84.95% |
| 1991 | -9.3 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 565.26 Million USD | 3.51% |
| 2024 Q2 | 666.28 Million USD | -0.78% |
| 2024 Q1 | 671.5 Million USD | 35.95% |
| 2023 Q4 | 493.94 Million USD | -28.11% |
| 2023 FY | 493.94 Million USD | -60.03% |
| 2023 Q3 | 687.1 Million USD | -23.91% |
| 2023 Q2 | 902.99 Million USD | -17.27% |
| 2023 Q1 | 1.09 Billion USD | -11.68% |
| 2022 Q1 | 1.07 Billion USD | 38.46% |
| 2022 Q4 | 1.23 Billion USD | -12.16% |
| 2022 FY | 1.23 Billion USD | 58.59% |
| 2022 Q3 | 1.4 Billion USD | 11.25% |
| 2022 Q2 | 1.26 Billion USD | 17.21% |
| 2021 Q2 | 672.92 Million USD | 3.74% |
| 2021 FY | 779.24 Million USD | 48.55% |
| 2021 Q4 | 779.24 Million USD | -4.73% |
| 2021 Q3 | 817.97 Million USD | 21.55% |
| 2021 Q1 | 648.65 Million USD | 23.66% |
| 2020 Q4 | 524.55 Million USD | -35.64% |
| 2020 FY | 524.55 Million USD | -41.54% |
| 2020 Q3 | 814.96 Million USD | -18.58% |
| 2020 Q2 | 1 Billion USD | -15.44% |
| 2020 Q1 | 1.18 Billion USD | 31.9% |
| 2019 Q3 | 903.28 Million USD | -2.41% |
| 2019 FY | 897.34 Million USD | 2.38% |
| 2019 Q4 | 897.34 Million USD | -0.66% |
| 2019 Q2 | 925.56 Million USD | -8.6% |
| 2019 Q1 | 1.01 Billion USD | 15.53% |
| 2018 FY | 876.49 Million USD | -18.34% |
| 2018 Q4 | 876.49 Million USD | 0.74% |
| 2018 Q3 | 870.03 Million USD | 0.52% |
| 2018 Q2 | 865.57 Million USD | 0.97% |
| 2018 Q1 | 857.27 Million USD | -20.13% |
| 2017 Q1 | 1.1 Billion USD | 5.36% |
| 2017 FY | 1.07 Billion USD | 2.31% |
| 2017 Q4 | 1.07 Billion USD | -4.28% |
| 2017 Q3 | 1.12 Billion USD | -1.54% |
| 2017 Q2 | 1.13 Billion USD | 3.03% |
| 2016 Q4 | 1.04 Billion USD | 11.97% |
| 2016 Q3 | 937.06 Million USD | -7.66% |
| 2016 FY | 1.04 Billion USD | 0.78% |
| 2016 Q2 | 1.01 Billion USD | -6.82% |
| 2016 Q1 | 1.08 Billion USD | 4.61% |
| 2015 Q3 | 1 Billion USD | 7.19% |
| 2015 Q4 | 1.04 Billion USD | 4.01% |
| 2015 Q2 | 933.77 Million USD | 7.66% |
| 2015 FY | 1.04 Billion USD | 80.6% |
| 2015 Q1 | 867.34 Million USD | 50.46% |
| 2014 Q4 | 576.46 Million USD | 33.36% |
| 2014 Q1 | 179.93 Million USD | 20.49% |
| 2014 FY | 576.46 Million USD | 286.02% |
| 2014 Q3 | 432.26 Million USD | 88.8% |
| 2014 Q2 | 228.95 Million USD | 27.24% |
| 2013 Q1 | 33.89 Million USD | 457.4% |
| 2013 Q3 | 134.03 Million USD | 13.1% |
| 2013 Q4 | 149.33 Million USD | 11.42% |
| 2013 FY | 149.33 Million USD | 1674.44% |
| 2013 Q2 | 118.5 Million USD | 249.59% |
| 2012 FY | -9.48 Million USD | -115.17% |
| 2012 Q1 | 71.7 Million USD | 14.68% |
| 2012 Q2 | 45.15 Million USD | -37.03% |
| 2012 Q4 | -9.48 Million USD | -171.34% |
| 2012 Q3 | 13.29 Million USD | -70.56% |
| 2011 Q1 | -22.79 Million USD | 3.54% |
| 2011 FY | 62.52 Million USD | 364.54% |
| 2011 Q4 | 62.52 Million USD | 362.03% |
| 2011 Q3 | -23.86 Million USD | -3.77% |
| 2011 Q2 | -22.99 Million USD | -0.86% |
| 2010 Q3 | -3.11 Million USD | -115.12% |
| 2010 FY | -23.63 Million USD | -237.77% |
| 2010 Q4 | -23.63 Million USD | -659.72% |
| 2010 Q2 | 20.58 Million USD | -63.2% |
| 2010 Q1 | 55.92 Million USD | 226.0% |
| 2009 Q4 | 17.15 Million USD | -58.32% |
| 2009 FY | 17.15 Million USD | -77.89% |
| 2009 Q3 | 41.15 Million USD | -27.2% |
| 2009 Q2 | 56.53 Million USD | -33.4% |
| 2009 Q1 | 84.89 Million USD | 9.39% |
| 2008 Q4 | 77.61 Million USD | -8.98% |
| 2008 Q3 | 85.26 Million USD | -3.98% |
| 2008 Q2 | 88.8 Million USD | 3.25% |
| 2008 Q1 | 86 Million USD | 369.37% |
| 2008 FY | 77.61 Million USD | 323.57% |
| 2007 Q4 | 18.32 Million USD | -27.85% |
| 2007 FY | 18.32 Million USD | 133.59% |
| 2007 Q2 | 40.95 Million USD | 45.02% |
| 2007 Q3 | 25.39 Million USD | -37.99% |
| 2007 Q1 | 28.23 Million USD | 151.77% |
| 2006 FY | -54.54 Million USD | 18.11% |
| 2006 Q1 | -35.33 Million USD | 46.94% |
| 2006 Q2 | -42.57 Million USD | -20.47% |
| 2006 Q3 | -43.66 Million USD | -2.55% |
| 2006 Q4 | -54.54 Million USD | -24.92% |
| 2005 Q4 | -66.6 Million USD | -16.38% |
| 2005 FY | -66.6 Million USD | -46.46% |
| 2005 Q1 | -44.05 Million USD | 3.12% |
| 2005 Q2 | -51.82 Million USD | -17.64% |
| 2005 Q3 | -57.22 Million USD | -10.43% |
| 2004 Q3 | -145.36 Million USD | 11.06% |
| 2004 Q4 | -45.47 Million USD | 68.72% |
| 2004 FY | -45.47 Million USD | 75.48% |
| 2004 Q1 | -179.11 Million USD | 3.41% |
| 2004 Q2 | -163.44 Million USD | 8.75% |
| 2003 FY | -185.43 Million USD | -64.37% |
| 2003 Q4 | -185.43 Million USD | -5.14% |
| 2003 Q1 | -132.46 Million USD | -17.42% |
| 2003 Q3 | -176.36 Million USD | -16.84% |
| 2003 Q2 | -150.95 Million USD | -13.95% |
| 2002 Q4 | -112.81 Million USD | -8.23% |
| 2002 Q2 | -67.62 Million USD | 7.47% |
| 2002 Q1 | -73.08 Million USD | -25.38% |
| 2002 FY | -112.81 Million USD | -93.55% |
| 2002 Q3 | -104.23 Million USD | -54.15% |
| 2001 FY | -58.28 Million USD | -55.28% |
| 2001 Q3 | -60.53 Million USD | -47.63% |
| 2001 Q2 | -41 Million USD | -111.37% |
| 2001 Q1 | -19.39 Million USD | 48.32% |
| 2001 Q4 | -58.28 Million USD | 3.71% |
| 2000 Q3 | -30.2 Million USD | 57.03% |
| 2000 Q4 | -37.53 Million USD | -24.28% |
| 2000 Q1 | -64.85 Million USD | -17.91% |
| 2000 FY | -37.53 Million USD | 31.75% |
| 2000 Q2 | -70.27 Million USD | -8.37% |
| 1999 Q2 | -97.6 Million USD | -19.75% |
| 1999 Q4 | -55 Million USD | 17.04% |
| 1999 FY | -55 Million USD | 44.83% |
| 1999 Q3 | -66.3 Million USD | 32.07% |
| 1999 Q1 | -81.5 Million USD | 18.25% |
| 1998 Q1 | -106.3 Million USD | -3.3% |
| 1998 Q3 | -137.2 Million USD | -7.95% |
| 1998 Q4 | -99.7 Million USD | 27.33% |
| 1998 FY | -99.7 Million USD | 3.11% |
| 1998 Q2 | -127.1 Million USD | -19.57% |
| 1997 Q4 | -102.9 Million USD | -0.88% |
| 1997 FY | -102.9 Million USD | 17.48% |
| 1997 Q1 | -105.3 Million USD | 15.56% |
| 1997 Q2 | -114.7 Million USD | -8.93% |
| 1997 Q3 | -102 Million USD | 11.07% |
| 1996 FY | -124.7 Million USD | 15.51% |
| 1996 Q4 | -124.7 Million USD | -1.8% |
| 1996 Q2 | -139.4 Million USD | -8.31% |
| 1996 Q3 | -122.5 Million USD | 12.12% |
| 1996 Q1 | -128.7 Million USD | 12.8% |
| 1995 Q4 | -147.6 Million USD | 19.83% |
| 1995 Q1 | -34.7 Million USD | -37.7% |
| 1995 FY | -147.6 Million USD | -485.71% |
| 1995 Q3 | -184.1 Million USD | -517.79% |
| 1995 Q2 | -29.8 Million USD | 14.12% |
| 1994 Q2 | -22.4 Million USD | -1.36% |
| 1994 Q1 | -22.1 Million USD | -16.93% |
| 1994 FY | -25.2 Million USD | -33.33% |
| 1994 Q4 | -25.2 Million USD | -22.33% |
| 1994 Q3 | -20.6 Million USD | 8.04% |
| 1993 FY | -18.9 Million USD | -9.88% |
| 1993 Q4 | -18.9 Million USD | 12.5% |
| 1993 Q3 | -21.6 Million USD | -0.47% |
| 1993 Q2 | -21.5 Million USD | -7.5% |
| 1993 Q1 | -20 Million USD | -16.28% |
| 1992 Q2 | -11.5 Million USD | -422.73% |
| 1992 Q1 | -2.2 Million USD | 76.34% |
| 1992 Q4 | -17.2 Million USD | -30.3% |
| 1992 FY | -17.2 Million USD | -84.95% |
| 1992 Q3 | -13.2 Million USD | -14.78% |
| 1991 Q3 | -10.3 Million USD | 50.48% |
| 1991 FY | -9.3 Million USD | 0.0% |
| 1991 Q2 | -20.8 Million USD | 0.0% |
| 1991 Q4 | -9.3 Million USD | 9.71% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -39.45 Million USD | 1352.023% |
| Applied DNA Sciences, Inc. | -5.91 Million USD | 8452.125% |
| Aspira Women's Health Inc. | -331 Thousand USD | 149329.003% |
| Biodesix, Inc. | 34.3 Million USD | -1339.788% |
| BioNexus Gene Lab Corp. | -5.79 Million USD | 8622.309% |
| bioAffinity Technologies, Inc. | -1.24 Million USD | 39840.581% |
| bioAffinity Technologies, Inc. | -1.24 Million USD | 39840.581% |
| Bionano Genomics, Inc. | 34.88 Million USD | -1316.054% |
| CareDx, Inc | -47.97 Million USD | 1129.573% |
| Check-Cap Ltd. | -24.75 Million USD | 2095.266% |
| Castle Biosciences, Inc. | -83.53 Million USD | 691.335% |
| DarioHealth Corp. | -7.54 Million USD | 6644.091% |
| Exact Sciences Corporation | 1.94 Billion USD | 74.661% |
| Fulgent Genetics, Inc. | -82.56 Million USD | 698.246% |
| Guardant Health, Inc. | 220.22 Million USD | -124.29% |
| ICON Public Limited Company | 3.56 Billion USD | 86.126% |
| Illumina, Inc. | 1.21 Billion USD | 59.312% |
| Intelligent Bio Solutions Inc. | -5.43 Million USD | 9192.198% |
| iSpecimen Inc. | -2.14 Million USD | 23101.906% |
| Standard BioTools Inc. | 46.5 Million USD | -962.117% |
| MDxHealth SA | 18.88 Million USD | -2515.557% |
| 23andMe Holding Co. | -141.37 Million USD | 449.396% |
| Medpace Holdings, Inc. | -103.32 Million USD | 578.043% |
| Myriad Genetics, Inc. | 88.1 Million USD | -460.667% |
| Mainz Biomed B.V. | 349.85 Thousand USD | -141086.492% |
| ENDRA Life Sciences Inc. | -2.43 Million USD | 20347.886% |
| NeoGenomics, Inc. | 269.19 Million USD | -83.494% |
| Neogen Corporation | 735.62 Million USD | 32.854% |
| Inotiv, Inc. | 382.14 Million USD | -29.255% |
| Natera, Inc. | -200.1 Million USD | 346.848% |
| OpGen, Inc. | 11.89 Million USD | -4053.657% |
| OPKO Health, Inc. | 230.68 Million USD | -114.124% |
| Psychemedics Corporation | 334 Thousand USD | -147788.623% |
| Prenetics Global Limited | -43.33 Million USD | 1239.782% |
| Prenetics Global Limited | -43.33 Million USD | 1239.782% |
| Precipio, Inc. | -386 Thousand USD | 128065.803% |
| Personalis, Inc. | -8.02 Million USD | 6257.417% |
| RadNet, Inc. | 1.14 Billion USD | 56.994% |
| Sera Prognostics, Inc. | -2.02 Million USD | 24528.684% |
| Sotera Health Company | 2.02 Billion USD | 75.612% |
| Neuronetics, Inc. | 2.79 Million USD | -17559.921% |
| Star Equity Holdings, Inc. | -15.33 Million USD | 3320.63% |
| Star Equity Holdings, Inc. | -15.33 Million USD | 3320.63% |
| Trinity Biotech plc | 63.73 Million USD | -674.991% |
| T2 Biosystems, Inc. | 33.8 Million USD | -1360.996% |
| Twist Bioscience Corporation | -192.4 Million USD | 356.728% |
| Exagen Inc. | -12.77 Million USD | 3967.429% |